For the MPN and MDS session, Dr. Bejar will debate the topic of whether molecular genetic testing should be routinely performed in cases of older persons with cytopenias/possible MDS, for the affirmative position.

http://imedex.com/hematologic-malignancies-debate-conference/archive/2017/agenda.asp